Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Avonex Market Report 2025

Avonex Global Market Report 2025 – By Type (Prefilled Syringe, Powder Form), Clinical Indication (Relapsing Forms Of Multiple Sclerosis (RMS), Clinically Isolated Syndrome (CIS), Relapse Rate Reduction In MS, Slowing Disability Progression, Long-term Disease Management In MS, Early-Stage MS Treatment), By Distribution Channel (Wholesalers, Retail Pharmacies, Direct-To-Patient (Dtp) Sales), By Application (Hospital, Drugs Store, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Avonex Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Avonex Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Avonex Market Definition

Avonex is a brand name for interferon beta-1a, a medication used primarily to treat relapsing forms of multiple sclerosis (MS). It helps reduce the frequency of MS relapses and slow the progression of physical disability. Avonex is an immunomodulator that works by modifying the immune system's activity, reducing inflammation and damage to the nervous system caused by MS.

The main types of avonex are prefilled syringes and powder forms. Prefilled syringes are single-dose containers that come ready to inject, pre-filled with a medication and equipped with a needle, designed for ease of use in various medical treatments. The clinical indication involved are Relapsing Forms Of Multiple Sclerosis (RMS), clinically isolated syndrome (CIS), relapse rate reduction in MS, slowing disability progression, long-term disease management in MS and early-stage MS treatment. It is distributed through various channels such as wholesalers, retail pharmacies, and direct-to-patient (DTP) sales for applications including hospitals, drug stores, and others.

Avonex Market Segmentation

The avonexmarket covered in this report is segmented –

1) By Type: Prefilled Syringe, Powder Form

2) Clinical Indication: Relapsing Forms Of Multiple Sclerosis (RMS), Clinically Isolated Syndrome (CIS), Relapse Rate Reduction In MS, Slowing Disability Progression, Long-term Disease Management In MS, Early-Stage MS Treatment

2) By Distribution Channel: Wholesalers, Retail Pharmacies, Direct-To-Patient (Dtp) Sales

3) By Application: Hospital, Drugs Store, Other Applications

Avonex Market Size and growth rate 2025 to 2029: Graph

Avonex Market Size 2025 And Growth Rate

The avonex market size has grown strongly in recent years. It will grow from $1,836.58 million in 2024 to $1,949.35 million in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased biogen's strategy and branding, increased patient retention and loyalty, growth in patient convenience, increased competition with newer therapies, increased attention to customized medication.

Avonex Market Growth Forecast

The avonex market size is expected to see strong growth in the next few years. It will grow to $2,439.17 million in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rise in multiple sclerosis (MS) prevalence, increasing preference for oral medications, rising patient support expectations, increasing clinical evidence supporting efficacy, increasing market share of injectable alternatives. Major trends in the forecast period include advanced data analytics, demand for biological indicators, utilization of 3d bioprinting, integration of immunomodulatory technology, use of nanotechnology.

Book your 30 minutes free consultation with our research experts

Contact Us

Avonex Market Driver: Rising Multiple Sclerosis Prevalence Fuels Growth Of The Avonex Market

The rise in multiple sclerosis (MS) prevalence is expected to drive the growth of the Avonex market going forward. Multiple sclerosis (MS) is a chronic autoimmune disease where the immune system mistakenly attacks the protective myelin sheath covering nerve fibers in the central nervous system, leading to communication disruptions between the brain and body. The increase in multiple sclerosis cases is likely due to better diagnosis, environmental factors including vitamin D deficiency, genetic predisposition, and changes in lifestyle and migration patterns. Avonex is required for multiple sclerosis (MS) because it helps reduce inflammation, decreases the frequency of relapses, and slows the progression of physical disability by modulating the immune system. For instance, in May 2024, according to a report published by the Multiple Sclerosis Trust, a UK-based charity, a new study discovered that the number of people living with multiple sclerosis in the UK had risen by nearly 13% by 2024. This includes a 15% increase in England, 10% in Scotland, 9% in Northern Ireland, and 8% in Wales. Therefore, the rise in multiple sclerosis (MS) prevalence is driving the growth of the Avonex market.

Global Avonex Market Major Players

Major companies operating in the avonex market include Biogen Inc

Global Avonex Market Trend: Strategic Partnerships Driving Innovation In The Avonex Market

The key trend in the avonex market is focusing on developing strategic partnerships to improve treatment options, patient outcomes, and the management of chronic diseases. Strategic partnerships are collaborative agreements between two or more organizations that leverage their complementary strengths, resources, or expertise to achieve mutual goals and enhance competitive advantage. For instance, June 2022, Biogen Inc., a US-based manufacturer of Avonex (interferon beta-1a), partnered with Happify Health, a US-based company that offers a digital mental health and wellness platform, to develop an AI-powered digital solution aimed at enhancing patient education and engagement for people living with multiple sclerosis (MS). This initiative helps individuals manage their care journey, access expert consultations, and explore treatment options while fostering a sense of community. By improving wellbeing and connecting users with others in the MS community, the solution empowers patients to take charge of their health.

Avonex Market Merger And Acquisition: Vanguard Group Acquires Stake In Biogen To Strengthen Investment Portfolio

In November 2024, Vanguard Group Inc., a US-based investment firm, acquired shares in Biogen Inc. for an undisclosed amount. The acquisition underscores Vanguard's strategy to diversify and enhance its investment portfolio. It highlights Vanguard's commitment to Biogen and its focus on investing in companies with strong growth potential and innovative product pipelines. Biogen Inc. is a US-based manufacturer of avonex.

Regional Outlook For The Global Avonex Market

North America was the largest region in the avonex market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avonex market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the avonex market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Avonex Market?

The avonex market consists of sales of monoclonal antibodies, spinal muscular atrophy medications, biosimilars and immunomodulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Avonex Industry?

The avonex market research report is one of a series of new reports from The Business Research Company that provides avonex market statistics, including avonex industry global market size, regional shares, competitors with a avonex market share, detailed avonex market segments, market trends and opportunities, and any further data you may need to thrive in the avonex industry. This avonex market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Avonex Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 CAGR of 5.8% from 2025 to 2034
Revenue Forecast In 2034 2024
Growth Rate 2019-2024
Base Year For Estimation 2025 - 2029 - 2034
Actual Estimates/Historical Data Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period 1) By Type: Prefilled Syringe, Powder Form
2) Clinical Indication: Relapsing Forms Of Multiple Sclerosis (RMS), Clinically Isolated Syndrome (CIS), Relapse Rate Reduction In MS, Slowing Disability Progression, Long-term Disease Management In MS, Early-Stage MS Treatment
2) By Distribution Channel: Wholesalers, Retail Pharmacies, Direct-To-Patient (Dtp) Sales
3) By Application: Hospital, Drugs Store, Other Applications
Market Representation Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope Biogen Inc
Country Scope Request for Sample
Key Companies Profiled Explore Purchase Options
Customization Scope
Pricing And Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Avonex Market Characteristics

    3. Avonex Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Avonex Market Trends And Strategies

    5. Avonex Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Avonex Growth Analysis And Strategic Analysis Framework

    6.1. Global Avonex PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Avonex Market Growth Rate Analysis

    6.4. Global Avonex Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    6.5. Global Avonex Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    6.6. Global Avonex Total Addressable Market (TAM)

    7. Global Avonex Market Pricing Analysis & Forecasts

    8. Avonex Market Segmentation

    8.1. Global Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Prefilled Syringe

    Powder Form

    8.2. Global Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Relapsing Forms Of Multiple Sclerosis (RMS)

    Clinically Isolated Syndrome (CIS)

    Relapse Rate Reduction In MS

    Slowing Disability Progression

    Long-term Disease Management in MS

    Early-Stage MS Treatment

    8.3. Global Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Wholesalers

    Retail Pharmacies

    Direct-To-Patient (Dtp) Sales

    8.4. Global Avonex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital

    Drug Stores

    Other Applications

    9. Global Avonex Market Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Avonex Market Regional And Country Analysis

    10.1. Global Avonex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. Global Avonex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Asia-Pacific Avonex Market

    11.1. Asia-Pacific Avonex Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Asia-Pacific Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Asia-Pacific Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. China Avonex Market

    12.1. China Avonex Market Overview

    12.2. China Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.3. China Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    12.4. China Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    13. India Avonex Market

    13.1. India Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. India Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. India Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. Japan Avonex Market

    14.1. Japan Avonex Market Overview

    14.2. Japan Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. Japan Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. Japan Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Australia Avonex Market

    15.1. Australia Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.2. Australia Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Australia Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. South Korea Avonex Market

    16.1. South Korea Avonex Market Overview

    16.2. South Korea Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. South Korea Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.4. South Korea Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Western Europe Avonex Market

    17.1. Western Europe Avonex Market Overview

    17.2. Western Europe Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Western Europe Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.4. Western Europe Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. UK Avonex Market

    18.1. UK Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. UK Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. UK Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Germany Avonex Market

    19.1. Germany Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Germany Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Germany Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. France Avonex Market

    20.1. France Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. France Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. France Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Avonex Market

    21.1. Eastern Europe Avonex Market Overview

    21.2. Eastern Europe Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. North America Avonex Market

    22.1. North America Avonex Market Overview

    22.2. North America Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. North America Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.4. North America Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. USA Avonex Market

    23.1. USA Avonex Market Overview

    23.2. USA Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. USA Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. USA Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. Canada Avonex Market

    24.1. Canada Avonex Market Overview

    24.2. Canada Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. Canada Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. Canada Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. South America Avonex Market

    25.1. South America Avonex Market Overview

    25.2. South America Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. South America Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. South America Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. Middle East Avonex Market

    26.1. Middle East Avonex Market Overview

    26.2. Middle East Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. Middle East Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. Middle East Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Africa Avonex Market

    27.1. Africa Avonex Market Overview

    27.2. Africa Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Africa Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.4. Africa Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Avonex Market Competitive Landscape And Company Profiles

    28.1. Avonex Market Competitive Landscape

    28.2. Avonex Market Company Profiles

    28.2.1. Biogen Inc Overview, Products and Services, Strategy and Financial Analysis

    29. Global Avonex Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Avonex Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Avonex Market

    32. Recent Developments In The Avonex Market

    33. Avonex Market High Potential Countries, Segments and Strategies

    33.1 Avonex Market In 2029 - Countries Offering Most New Opportunities

    33.2 Avonex Market In 2029 - Segments Offering Most New Opportunities

    33.3 Avonex Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Avonex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Avonex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Avonex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: South Korea, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: South Korea, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Western Europe, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: UK, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: UK, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Germany, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Germany, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Germany, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: France, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: France, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: France, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Eastern Europe, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: North America, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: North America, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: USA, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Canada, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Canada, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: South America, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: South America, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: South America, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Middle East, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Middle East, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Africa, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Africa, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Africa, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Biogen Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Avonex Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Avonex Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Avonex Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: South Korea, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: South Korea, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Western Europe, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: UK, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: UK, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Germany, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Germany, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Germany, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: France, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: France, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: France, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Eastern Europe, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: North America, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: North America, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: USA, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Canada, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Canada, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: South America, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: South America, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: South America, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Middle East, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Middle East, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Africa, Avonex Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Africa, Avonex Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Africa, Avonex Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Biogen Inc Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the antiglaucoma drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025 – By Type (Losmapimod, SHP-627, Sparsentan, TM-5484, Other Types), By Treatment (Corticosteroids, Immunosuppressive Drugs, Angiotensin Converting Enzymes (ACE) Inhibitors, A.R. Blockers, Diuretics, Other Treatments), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multiple Sclerosis Drugs Global Market Report 2025 – By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Other Drug Classes), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Stores), By Route Of Administration (Oral Drugs, Parenteral Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Atherosclerosis Drugs Global Market Report 2025 – By Drug Class (Anti-Platelet Medications, Fibric Acid And Omega-3 Fatty Acid Derivatives, Angiotensin-Covering Enzyme (ACE) Inhibitors, Diuretics, Cholesterol Lowering Medication, Beta Blockers, Calcium Channel Blockers, Other Drug Classes), By Route Of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multiple Sclerosis Drugs Global Market Report 2025 – By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Other Drug Classes), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Stores), By Route Of Administration (Oral Drugs, Parenteral Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multiple Myeloma Global Market Report 2025 – By Treatment (Medications, Radiation Therapy, Stem Cell Transplant, Other Treatments), By Diagnosis (Blood Tests, Bone Marrow Biopsy, Urine Tests, Imaging Tests), By Disease Type (Active Multiple Myeloma, Smoldering Multiple Myeloma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multiple Myeloma Drugs Global Market Report 2025 – By Drug Type (Immunomodulatory Drugs, Proteasome Inhibitors, Histone Deacetylase Inhibitors, Monoclonal Antibody Drugs, Steroids, Other Drug Types), By Therapy (Targeted Therapy, Biologic Therapy, Chemotherapy, Other Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By End-User (Men, Women) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multiplex Assays Global Market Report 2025 – By Type (Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types), By Identification Technology (Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies), By Detection Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies), By Application (Research And Development, Clinical Diagnostics), By End User (Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multiplex Biomarker Imaging Global Market Report 2025 – By Component Type (Instruments, Software, Services), By Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent In The Situ Hybridization (FISH) Assay, Toponome Imaging System (TIS)), By Application (Drug Safety, Oncology Studies, Genetic Characterization Studies), By End User (Research Institutes Government And Private, Clinical Labs, Pharmaceutical And Biotechnology) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Avonex market?

Avonex is a brand name for interferon beta-1a, a medication used primarily to treat relapsing forms of multiple sclerosis (MS). It helps reduce the frequency of MS relapses and slow the progression of physical disability. Avonex is an immunomodulator that works by modifying the immune system's activity, reducing inflammation and damage to the nervous system caused by MS. For further insights on the Avonex market, request a sample here

How will the Avonex market drivers and restraints affect the market dynamics? What forces will shape the Avonex industry going forward?

The Avonex market major growth driver - Rising Multiple Sclerosis Prevalence Fuels Growth Of The Avonex Market. For further insights on the Avonex market, request a sample here

What is the forecast market size or the forecast market value of the Avonex market?

The Avonex market size has grown strongly in recent years. The avonex market size has grown strongly in recent years. It will grow from $1,836.58 million in 2024 to $1,949.35 million in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased biogen's strategy and branding, increased patient retention and loyalty, growth in patient convenience, increased competition with newer therapies, increased attention to customized medication. The avonex market size is expected to see strong growth in the next few years. It will grow to $2,439.17 million in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rise in multiple sclerosis (MS) prevalence, increasing preference for oral medications, rising patient support expectations, increasing clinical evidence supporting efficacy, increasing market share of injectable alternatives. Major trends in the forecast period include advanced data analytics, demand for biological indicators, utilization of 3D bioprinting, integration of immunomodulatory technology, use of nanotechnology. For further insights on the Avonex market, request a sample here

How is the Avonex market segmented?

The avonexmarket covered in this report is segmented –
1) By Type: Prefilled Syringe; Powder Form
2) Clinical Indication: Relapsing Forms Of Multiple Sclerosis (RMS); Clinically Isolated Syndrome (CIS); Relapse Rate Reduction In MS; Slowing Disability Progression; Long-term Disease Management In MS; Early-Stage MS Treatment
2) By Distribution Channel: Wholesalers; Retail Pharmacies; Direct-To-Patient (Dtp) Sales
3) By Application: Hospital; Drugs Store; Other Applications For further insights on the Avonex market, request a sample here

Which region has the largest share of the Avonex market? What are the other regions covered in the report?

North America was the largest region in the avonex market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avonex market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Avonex market, request a sample here.

Who are the major players in the Avonex market?

Major companies operating in the avonex market include Biogen Inc . For further insights on the Avonex market, request a sample here.

What are the key trends in the Avonex market?

Major trends in the Avonex market include Strategic Partnerships Driving Innovation In The Avonex Market. For further insights on the Avonex market, request a sample here.

What are the major opportunities in the Avonex market? What are the strategies for the Avonex market?

For detailed insights on the major opportunities and strategies in the Avonex market, request a sample here.

How does the Avonex market relate to the overall economy and other similar markets?

For detailed insights on Avonex's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Avonex industry?

For detailed insights on the mergers and acquisitions in the Avonex industry, request a sample here.

What are the key dynamics influencing the Avonex market growth? SWOT analysis of the Avonex market.

For detailed insights on the key dynamics influencing the Avonex market growth and SWOT analysis of the Avonex industry, request a sample here.